Actively Recruiting
An Integrated, Virtual and On-Demand Solution to Avoid Emergency Department Utilization
Led by Geisinger Clinic · Updated on 2025-06-29
3200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
The trial investigates a virtual, on-demand telemedicine program designed for patients who frequently visit the emergency department (ED) and have both physical health conditions and behavioral health concerns. The purpose is to evaluate whether this integrated telemedicine program can reduce the number of ED visits within 120 days after the first alert. Researchers will compare this program to standard care to assess its impact on ED utilization. Participants will be randomly assigned to either the treatment group, which receives full access to the integrated telemedicine program, or the control group, which continues with standard care without the telemedicine intervention. The telemedicine program offers short-term support from a virtual team including behavioral health providers and community health workers. Once patients stabilize, they transition to ongoing care with primary care and behavioral health providers within the Geisinger Health System. During the study, participants will be monitored for ED visits within 120 days after their first alert to the program. Researchers will collect data on emergency department utilization and analyze results using an intent-to-treat approach. The study plans to enroll up to 3200 patients, with randomization ending by December 31, 2025. Participation involves receiving invitations via text, email, or phone calls and continuing routine care as usual.
CONDITIONS
Brief Title
Integrated Telemedicine Program Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- At least 4 Geisinger emergency department visits in the last 6 months
- Member of Geisinger Health Plan (GHP) insurance
- Has a Geisinger Primary Care Provider (PCP)
- Receiving care at a participating Geisinger facility such as Geisinger Lewistown Hospital, Geisinger Medical Center, or others listed in the criteria
You will not qualify if you...
- Receiving care in departments deemed ineligible by the study team
- Diagnosed with alcohol and substance-related disorders
- Scheduled to receive inpatient care
- Coded as Level 1 in the emergency department (seeking life-saving measures)
- Has Intellectual Disability or Traumatic Brain Injury
- Currently seeing a behavioral health provider
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Duration - Up to 120 days
Participants receive short-term bridge support through an integrated telemedicine program from a virtual team including a behavioral health provider and a Community Health Worker.
Regular virtual visits as part of the telemedicine program
Duration - Monitoring continues after the telemedicine program ends up to 120 days from initial enrollment
Participants transition from bridge support to ongoing care with their Primary Care Provider and Behavioral Health Provider, with monitoring of emergency department visits.
Additional follow-up visits depending on care needs
Trial Site Locations
Total: 1 location
1
Geisinger Clinic
Danville, Pennsylvania, United States, 17822
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here